medigraphic.com

2005, Number 4

<< Back Next >>

Rev Fac Med UNAM 2005; 48 (4)

Arterial hypertension treatment

Hernández RR

Language: Spanish
References: 20
Page: 134-138
PDF size: 49.80 Kb.


ABSTRACT

A comparative, prospective and double-blind trial was performed for evaluating the usefulness and tolerance of nifedipine 30 mg and a combined preparation consisting of 50 mg atenolol and 12.5 mg chlorthalidone in ambulatory patients with severe systemic arterial hypertension (systolic › 180 mmHg and diastolic › 110 mmHg. There was 96 patients, 47 in each group. After six weeks of treatment the results of the study showed decreases of both, the systolic levels to 140 mmHg and diastolic levels to 90 mmHg of blood pressure, in sixty-four percent of patients in each group. The side effects were minimal. There was no mortality.


REFERENCES

  1. Kannel WB, Wilson WF. An update on coronary risk factors. Med Clin North Am 1995; 79: 951-7.

  2. Stambler I, Stambler R, Neaton ID. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598-615.

  3. Joint National Committee. The sixth. report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC VI). Arch Intern Med 1997; 157: 2413-45.

  4. Guidelines Subcomitte WHO. 1999 World Health Organization-International Society of Hypertension Guidelines for de Management of Hypertension. Hypertension 1999; 17: 151-83.

  5. Moragrega AJL y cols. Definición, causas, clasificación, epidemiología y prevención primaria, II Consenso Nacional de Hipertensión Arterial. Rev Mex Cardiol 2001; 12: 9-18.

  6. Psaty BM, Smith NL, Siscovick DS. Health outcomes associated with antihypertensive therapies used as first. Line agents: a systematic review and meta-analysis. JAMA 1997; 277: 739-45.

  7. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-18.

  8. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967-78.

  9. Lombera RF y cols. Guías de práctica clínica de la SEC en hipertensión arterial. Rev Esp Cardiol 2000; 53: 74-6.

  10. Setaro JF, Black HR. Refractory hipertensión. N Engl J Med 1992; 327: 543-7.

  11. Amodeo C, Brandao AP, Gioge DM. Multicenter National Study for the evaluation of the efficace and tolerance of nifedipine oral release sustem in mild to moderate hypertension. Arq Bras Cardiol 1995; 64: 483-7.

  12. Grundy JS, Foster RT. The nifedipine gastrointestinal therapeutic system. Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin Pharmacokinet 1996; 30: 28-51.

  13. Batlouni M, Leite Luna R, Castro I. Multicenter comparative study of felodipine-ER and nifedipine-OROS in the treatment of mild-to-moderate arterial hypertension. Arq Bras Cardiol 1996; 66: 247-51.

  14. Taverner D, Marley J, Tonkin AL. Coss-over comparison of nifedipine Oros and felodipine extended with blind 24 h ambulatory blood pressure assessments. Clin Exp Pharmacol Physiol 1999; 26: 909-13.

  15. The IPPPSH collaborative Group. Cardiovascular Risk and risk factors in a randomized trial of treatment based on the betablocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension. J Hypertens. 1985; 3: 379-92.

  16. Prichand NBC, Cruickshand JM. Beta-blockade in hypertension: past, present and future. Laragh JH, Brenner BM. Editors. Hypertension, pathophysiology diagnosis and management. Nueva York. Raven Press, 1995: 2827-59.

  17. Curry RC Jr, Schwartz KM, Urban PL. Atenolol and chlorthalidone therapy for hypertension: a double blind comparison. South Med J 1998; 81: 1401-11.

  18. Pilgaard S, Palmelund VO, Svendsen TL. A comparative study of atenolol and the combined preparation atenolol/chlorthalidone in essential hypertension. Ugeskr Laeger 1990; 152: 1083-86.

  19. Philipp T, Anlauf M, Distler A et al. Randomized, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendepine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 1997; 315: 154-9.

  20. Dahlof B, Zanchetti A, Diez J et al. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension left ventricular hypertrophy. J Hypertens 2002; 20: 1855-64.




2020     |     www.medigraphic.com